Related Experiment Videos
[Hepatitis B in children--diagnosis, follow-up and treatment]
Karl-Olaf Wathne1, Astrid Rojahn
1Seksjon for infeksjonssykdommer Barnemedisinsk avdeling Ullevål universitetssykehus 0407 Oslo. karl-olaf.wathne@ulleval.no
Insights
Chronic hepatitis B infection affects millions globally. This study outlines clinical management recommendations for children in Norway, emphasizing early immunization and pediatric follow-up for timely treatment eligibility.
Area of Science:
- Hepatology
- Pediatrics
- Infectious Diseases
Context:
- Chronic hepatitis B virus (HBV) infection is a global health concern affecting 350 million people.
- Increasing immigration in Norway leads to a rise in pediatric chronic HBV cases.
- A consensus meeting of Norwegian pediatricians addressed the need for specific clinical management guidelines.
Purpose:
- To develop evidence-based recommendations for the diagnosis, follow-up, and treatment of chronic hepatitis B in children.
- To provide guidance for Norwegian pediatricians managing pediatric HBV infections.
- To align clinical practice with international standards and regional experiences.
Summary:
- Recommendations cover diagnosis, monitoring, and treatment eligibility for pediatric chronic HBV.
- Emphasizes timely infant immunization for children at risk of maternal transmission.
- Highlights the crucial role of pediatricians in long-term management and treatment identification.
Impact:
- Aims to improve the clinical management of pediatric hepatitis B in Norway.
- Facilitates early detection and intervention for children with chronic HBV.
- Contributes to reducing the long-term health consequences of pediatric hepatitis B infection.
Abstract:
350 million people worldwide are chronic carriers of the hepatitis B virus. Mainly because of immigration, the number of children with chronic hepatitis B infection in Norway is also increasing, although the absolute number is still small. In April 2001, a group of Norwegian paediatricians interested in infectious diseases held a meeting to discuss the clinical management of chronic hepatitis B in children and develop recommendations. The recommendations are based on current European and American guidelines, experience from England and Sweden, and a review of the literature. International epidemiological data and data from Norway are briefly presented, followed by recommendations regarding diagnosis, follow-up and treatment of chronic hepatitis B infection in children. Children at risk of contracting hepatitis B from their mothers should be immunized shortly after birth. Paediatricians should follow up children with chronic hepatitis B infections in order to identify those who may be eligible for treatment.